ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,800, issued on Jan. 20, was assigned to KYOWA KIRIN Co. LTD. (Tokyo).
"Therapeutic agent for Parkinson's disease" was invented by Tomoyuki Kanda (Tokyo), Akihisa Mori (Tokyo), Hiroki Kitabayashi (Tokyo), Takanobu Nomura (Tokyo) and Nobutaka Hattori (Tokyo).
According to the abstract* released by the U.S. Patent & Trademark Office: "A therapeutic agent for Parkinson's disease containing istradefylline as an effective ingredient being characterized in exhibiting more expression of a shortening effect of the OFF time by administration to a patient of Parkinson's disease of 65 or more years old as compared with administration to a patient of Parkinson's disease of younger than 65 yea...